Retatrutide trials report less knee osteoarthritis pain; ixekizumab plus tirzepatide shows exploratory ACR50 benefits in psoriatic arthritis.
|Articles|May 1, 2006
Editor’s Commentary
Author(s)Susan Kweskin
At ConsultantLive you can find practical answers to questions that arise in daily practice.
Advertisement
Where can you get practical answers to questions thatarise in daily practice?We invite you to turn to a familiar source.We've recently updated and enriched ourWeb site--www.ConsultantLive.com--and we inviteyou to go online to look around. You'll find:
- An online table of contents that makes it easy to findout what's in each month's issue.
- The entire contents of the issue you now hold in yourhands. If you want a copy of the article by Drs Volk andHolman ("Exercise: How Much Is Enough for CardiovascularHealth?) that appears on page 589, for example,you can print it out--or you can e-mail it to a colleague.
- An easily searchable archive of our peer-reviewed articlesand service features that have recently appeared inConsultant. If you want practical information about howto help prevent or manage cardiovascular disease, for example, you may find what you're looking for in only a couple of clicks. (You can either search by key wordsor browse through the contents of 35 categories.)
- Hundreds of clinical images. It's now easy to searchour Photoclinic collection-and Dermclinic cases arealso now online. You'll also find collections of clinicalimages on over 40 clinical themes.
- Over 40 hours of free CME credit.
- A place to request or renew your subscription.
- All the service features you enjoy each month inConsultant, including What's The "Take Home"?, PhotoQuiz, What's Wrong With This Picture?, Consultations& Comments, and What's Your Diagnosis?.
We invite you to log on today and see for yourselfwhat an online version of Consultant has to offer.
Advertisement
Related to this article
Asundexian reduced relative ischemic stroke risk by 26% alongside antiplatelet therapy, with bleeding concerns in older adults.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Advertisement
Advertisement